VAERS reports by lot

GSK Hepatitis A lot 4T93R: VAERS reports

35 VAERS reports list lot 4T93R as a GSK Hepatitis A vaccine, received between 2024-07-20 and 2025-11-22. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
0%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1048%
General / Systemic (non-local)314%
Cardiac / Cardiovascular210%
Dermatological (non-injection-site)210%
Allergic / Anaphylactic15%
Musculoskeletal15%
Psychiatric / Neuropsychiatric15%
Injection-site / Local reaction15%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
California4
Massachusetts3
Oklahoma3
Michigan2
Arizona2
Texas2
District of Columbia2
Arkansas2
Indiana1
Wyoming1
Nevada1
New Mexico1

Reports by month received

MonthReportsBar
2024-071
2024-082
2024-104
2024-114
2024-122
2025-012
2025-022
2025-032
2025-042
2025-074
2025-081
2025-097
2025-112

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby GSK Hepatitis A lots (A–Z): 47XP4 · 4EA77 · 4H37Y · 72T95 · 74EM4 · 772YT

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.